Single-Arm Phase II Study of Stereotactic Body Radiation Therapy Concurrent With Nelfinavir for Oligometastases
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Nelfinavir (Primary)
- Indications Cancer metastases
- Focus Therapeutic Use
- 08 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 24 Jul 2013 Planned initiation date changed from 1 Feb 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 24 Jul 2013 Planned number of patients changed from 30 to 42 as reported by ClinicalTrials.gov.